Detailed answers about BEAUMONT MEDCHEM DMPK CONSULTING LIMITED, including incorporation, status, business activity, and accounts information.
When was BEAUMONT MEDCHEM DMPK CONSULTING LIMITED founded?
BEAUMONT MEDCHEM DMPK CONSULTING LIMITED was officially incorporated on 18 September 2025 and is registered under company number 16725872. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BEAUMONT MEDCHEM DMPK CONSULTING LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BEAUMONT MEDCHEM DMPK CONSULTING LIMITED?
BEAUMONT MEDCHEM DMPK CONSULTING LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BEAUMONT MEDCHEM DMPK CONSULTING LIMITED do?
BEAUMONT MEDCHEM DMPK CONSULTING LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is BEAUMONT MEDCHEM DMPK CONSULTING LIMITED's registered address?
The registered office address of BEAUMONT MEDCHEM DMPK CONSULTING LIMITED is SPITFIRE HOUSE 19 FALCON COURT, PRESTON FARM INDUSTRIAL ESTATE, STOCKTON-ON-TEES, CLEVELAND, UNITED KINGDOM, TS18 3TU. This is the official address filed with Companies House for legal and statutory correspondence.
Is BEAUMONT MEDCHEM DMPK CONSULTING LIMITED financially stable?
Financial accounts for BEAUMONT MEDCHEM DMPK CONSULTING LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.